SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-13-373397
Filing Date
2013-09-20
Accepted
2013-09-20 16:36:33
Documents
3
Group Members
CRAIG A. COLLARD

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D AMENDMENT NO. 6 d599417dsc13da.htm SC 13D/A 91392
2 EX-10.11 d599417dex1011.htm EX-10.11 60586
3 EX-10.18 d599417dex1018.htm EX-10.18 5588
  Complete submission text file 0001193125-13-373397.txt   159359
Mailing Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518
Business Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518 919-678-6611
CORNERSTONE THERAPEUTICS INC (Subject) CIK: 0001145404 (see all company filings)

IRS No.: 043523569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-79887 | Film No.: 131108267
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518
Business Address 1255 CRESCENT GREEN DRIVE SUITE 250 CARY NC 27518 919-678-6611
Cornerstone BioPharma Holdings, Ltd. (Filed by) CIK: 0001434508 (see all company filings)

IRS No.: 201586225 | State of Incorp.: 1A | Fiscal Year End: 1231
Type: SC 13D/A